Center for Molecular Immunology (CIM)

Cultivation of superior cells, diagnosis-treatment of cancer and other autoimmune diseases, recombinant proteins and monoclonal antibodies.
calle 216 esquina 15, Atabey
216 street
Postal code
(+53)7271 7933
Contact person's name
Sonia Ponce de León (Social communicator)
Short description of the company
The Center for Molecular Immunology (CIM) is a closed-cycle Cuban biotechnological institution (research-development, production and marketing) that, based on the cultivation of superior cells, directs its basic research, development and manufacture of products to the diagnosis-treatment of cancer and other autoimmune diseases. It also has a production capacity of several kilograms per year of recombinant proteins and monoclonal antibodies.
Company`s description
The CIM has a portfolio of around 20 products, in different stages of development. It has the technology to develop new recombinant products. It also has experience in the establishment of quality systems related to the manufacture and release of biotechnological products and the transfer of these manufacturing technologies. It has the possibility of establishing collaboration and/or negotiations that include all its experience.
Partner search
For joint development / commercial representation
therapeutic drugs for the treatment of autoimmune and neurodegenerative diseases
Short content description
For joint development of new drugs in the field and/or for commercial representation
The programme is co-financed by the Slovenian Enterprise Fund and the European Union, namely from the European Fund for Regional Development. It is carried out on the basis of the Substantial Support of Fund Recipients (SME) programme from 2018 to 2023 within the framework of the Operational Programme for the Implementation of European Cohesion Policy from 2014 to 2020.